help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-106-5-1386
Endocrinology Vol. 106, No. 5 1386-1391
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSENBAUM, R. L.
Right arrow Articles by SURKS, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSENBAUM, R. L.
Right arrow Articles by SURKS, M. I.

Changes in Thyroidal Economy in Rats Bearing Transplantable Walker 256 Carcinomas*

ROBERT L. ROSENBAUM, SUSAN J. MATURLO and MARTIN I. SURKS

Division of Endocrinology and Metabolism, Department of Medicine, Montefiore Hospital and Medical Center, and the Albert Einstein College of Medicine Bronx, New York 10467

Address all correspondence and requests for reprints to: M. I. Surks, M.D., Montefiore Hospital and Medical Center, 111 East 210th Street, Bronx, New York 10467.

Abstract

Rats bearing transplanatable Walker 256 carcinomas have decreased hepatic nuclear T3 receptor concentration and decreased plasma concentrations of total and free T4 and T3. In the present studies, we investigated the mechanisms whereby plasma T4 is decreased in tumor-bearing (T) rats. Mean plasma T4 concentrations were significantly decreased in thyroidectomized T rats receiving daily treatment with T4 (3 µg/100 g BW). When tumor size was 6.5 ± 0.8% of body weight, plasma T4 was only 28% of control. This observation suggested alterations in the extrathyroidal metabolism of T4 in T rats. Measurements of plasma T4 binding and metabolism in groups of control (C) and T rats showed that the earliest change in thyroidal economy in rats with small neoplasms was a significant decrease in plasma T4 binding, and this was associated with a significant and proportional increase in the T4 MCR. With increasing tumor size, decreased plasma binding contributed to a smaller degree to the persistent elevation in the rate of T4 metabolism. This finding suggested that cellular processes involved in T4 metabolism were stimulated in T rats. Despite an increased rate of T4 metabolism in T rats, T4 turnover' (nanograms per 100 g BW/h) remained unchanged from C or was significantly decreased. This appeared to be due to the fact that plasma TSH in T rats was similar to that in C rats, and thyroidal activity, assessed by the thyroid to serum iodide concentration ratio, was decreased in T rats. Thus, the decrease in plasma T4 in T rats appears to be due to a decrease in plasma T4 binding, an increase in the rate of cellular T4 metabolism, a failure of the hypothalamic-pituitary axis to augment TSH secretion in response to decreased plasma T4 and T3 concentrations, and a decrease in thyroidal activity based on either hyporesponsiveness to circulating TSH or secretion of abnormal TSH with decreased biological activity. (Endocrinology 106: 1386, 1980)

Footnotes

* This work was supported by NIH Grants 1R01-CA-164363-04 and 1R01-CA-24604-01 and NIH Training Grant Am-07004-05 (to S.J.M.).

Received August 10, 1979.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society